News

Journal of Opioid Management Study

Millennium Health Publication in Journal of Opioid Management Provides Encouraging Data on Drug Use Trends in Patients Treated in Pain Management Practices Prescribed Opioids

SAN DIEGO, Calif. – September 7, 2022 – A study published in Journal of Opioid Management, led by Millennium Health researchers and co-authored by Kevin Zacharoff, MD, FACIP, FACPE, FAAP of Stony Brook University, explored the presence of illicit substances in definitive urine drug test (UDT) results in patients prescribed opioids.Read More

UnitedHealthcare Preferred Lab Network

Millennium Health Selected for the UnitedHealthcare Preferred Lab Network

SAN DIEGO, Calif. – August 31, 2022 – Millennium Health is pleased to announce that for the third year in a row, we have been chosen to be a part of the UnitedHealthcare Preferred Lab Network (PLN). Read More

Millennium UDT Update

Expanding Our Novel Psychoactive Substances Test Offerings

SAN DIEGO, Calif. – August 15, 2022 – We are pleased to announce that, as of Monday, August 15, 2022, we are updating our definitive urine drug testing (UDT) menu to expand our novel psychoactive substances test offerings, based on surveillance data from the DEA and Center for Forensic Science Research and Education (CFSRE). Read More

JAMA Study with OSU

Millennium Health and Ohio State University Researchers Work to Save Lives Amid the Substance Use Crisis with Study Published in JAMA Network Open

SAN DIEGO, Calif. – June 8, 2022 – A JAMA Network Open study, led by Millennium Health researchers, and co-authored by Rebecca Jackson, MD and Soledad Fernandez, PhD, of The Ohio State University College of Medicine, demonstrates a strong correlation between urine drug test (UDT) results and drug overdose deaths presenting a new opportunity in the fight against our nation’s substance use crisis.

Read More

NIDA-Funded Research with UC

Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction

SAN DIEGO, Calif. – May 10, 2022Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction. 

Read More

Oregon: Increase in Fentanyl Use

Oregon Experiencing Substantial Increase in Fentanyl Use for 2022

SAN DIEGO, Calif. – May 4, 2022 – A dramatic increase in drug overdose deaths, primarily due to illicit fentanyl, is being reported across the U.S.1 Contributing to these deaths is the proliferation of counterfeit pills often containing fentanyl that are nearly impossible to distinguish from authentic medications.2

Read More

Dr. Passik | BOD for IHFDA

Millennium Health VP, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD Appointed to Board of Directors for International Health Facility Diversion Association

SAN DIEGO, Calif. – March 29, 2022 – The International Health Facility Diversion Association (IHFDA) has tapped the expertise of Millennium Health’s Vice President, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD for its Board of Directors. Read More

Signals Report Volume 4

Millennium Health Signals Report™ Volume 4 Highlights Substantial Changes in Illicit Drug Use Trends

Report Provides Recent Findings Regarding Known Contributors to Drug Overdose Deaths

SAN DIEGO, Calif. – February 9, 2022 – Drug overdose deaths in the U.S. are the highest ever recorded and are primarily driven by illicit fentanyl and methamphetamine.1Read More

2021 Clinical Recap

SAN DIEGO, Calif. – January 19, 2022 – Celebrating the New Year with a look back at some of our important work from 2021. Many exciting things to come in 2022!Read More